| Tocilizumab: therapy and safety management. | |
| | |
MedLine Citation:
|
PMID: 20610315 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVES: To develop fact sheets about tocilizumab, in order to assist physicians in the management of patients with inflammatory joint disease. METHODS: 1. selection by a committee of rheumatology experts of the main topics of interest for which fact sheets were desirable; 2. identification and review of publications relevant to each topic; 3. development of fact sheets based on three levels of evidence: evidence-based medicine, official recommendations, and expert opinion. The 20 experts were rheumatologists and invited specialists in other fields, and they had extensive experience with the management of RA. They were members of the CRI (Club Rhumatismes et Inflammation), a section of the Société Francaise de Rhumatologie. Each fact sheet was revised by several. experts and the overall process was coordinated by three experts. RESULTS: Several topics of major interest were selected: contraindications of tocilizumab; the management of adverse effects and concomitant diseases that may develop during tocilizumab therapy; and the management of everyday situations such as pregnancy, surgery, and immunizations. After a review of the literature and discussions among experts, a consensus was developed about the content of the fact sheets presented here. These fact sheets focus on several points: Several topics of major interest were selected: contraindications of tocilizumab; the management of adverse effects and concomitant diseases that may develop during tocilizumab therapy; and the management of everyday situations such as pregnancy, surgery, and immunizations. After a review of the literature and discussions among experts, a consensus was developed about the content of the fact sheets presented here. These fact sheets focus on several points: 1. in RA, initiation and monitoring of tocilizumab therapy, management of patients with specific past histories, and specific clinical situations such as pregnancy; 2. diseases other than RA, such as juvenile idiopathic arthritis; 3. models of letters for informing the rheumatologist and general practitioner; 4. and patient information. CONCLUSION: These tocilizumab fact sheets built on evidence-based medicine and expert opinion will serve as a practical tool for assisting physicians who manage patients on tocilizumab therapy. They will be available continuously at www.cri-net.com and updated at appropriate intervals. |
| | |
Authors:
|
Thao Pham; Pascal Claudepierre; Arnaud Constantin; Michel de Bandt; Bruno Fautrel; Laure Gossec; Jacques-Eric Gottenberg; Philippe Goupille; Séverine Guillaume; Eric Hachulla; Charles Masson; Jacques Morel; Xavier Puéchal; Alain Saraux; Thierry Schaeverbeke; Daniel Wendling; Eric Bruckert; Stanislas Pol; Xavier Mariette; Jean Sibilia; |
Related Documents
:
|
15185195 - Sir howard walter florey--the force behind the development of penicillin. 16710545 - Benchmarking progress in tackling the challenges of intellectual property, and access t... 12709105 - The characteristics, qualities and skills of practice developers. 16456635 - Urban environmental management in shanghai: achievements, problems, and prospects. 22131735 - Effect of mahayavanala roma kshara and dhanyaka gokshura ghrita in benign prostatic hyp... 8948205 - Sonic instruments in root canal therapy. |
Publication Detail:
|
Type: Consensus Development Conference; Journal Article Date: 2010-06-17 |
Journal Detail:
|
Title: Joint, bone, spine : revue du rhumatisme Volume: 77 Suppl 1 ISSN: 1778-7254 ISO Abbreviation: Joint Bone Spine Publication Date: 2010 Jun |
Date Detail:
|
Created Date: 2010-07-08 Completed Date: 2010-10-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100938016 Medline TA: Joint Bone Spine Country: France |
Other Details:
|
Languages: eng Pagination: S3-100 Citation Subset: IM |
Copyright Information:
|
Copyright (c) 2010 Elsevier Masson SAS. All rights reserved. |
Affiliation:
|
Service de Rhumatologie, CHU Conception, Marseille, France. thao.pham@mail.ap-hm.fr |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal
/
adverse effects,
contraindications,
therapeutic use* Arthritis, Rheumatoid / drug therapy* Evidence-Based Medicine Humans Patient Education as Topic Risk Factors Safety Management |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/tocilizumab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Clinical effectiveness: what does it mean for practitioners - and cats?
Next Document: Laparoscopic total mesorectal excision.